Recursion 19 févr. 2026 Nvidia Dumped It, Cathie Wood Bought It. A Pharma Stock Is Splitting the Market. - Barron's
Recursion 25 janv. 2026 Will Nvidia-Backed BioHive-2 and Big Pharma Alliances Redefine Recursion Pharmaceuticals' (RXRX) Narrative - Yahoo Finance
Recursion 1 janv. 2026 Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy. - The Motley Fool
Recursion 1 déc. 2025 Recursion’s Incoming CEO on Turning AI Drugs Into Clinical Proof Points - Genetic Engineering and Biotechnology News
Recursion 21 nov. 2025 Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results - statnews.com
Recursion 21 nov. 2025 Recursion seeks to deliver results, and a VC sees a wave of M&A coming - statnews.com